COMMUNIQUÉS West-GlobeNewswire

OV - First prostate cancer patient included in Oncology Venture's Phase 2 study of Irofulven for personalized treatment
18/10/2018
Hoersholm, Denmark, October 18, 2018 - Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) announces the inclusion of the first patient in a Phase 2 study of Irofulven - a drug candidate that exploits cancer [...]
Whistler Medical Marijuana Secures Cultivation Licence for Flagship Pemberton Facility
18/10/2018
WHISTLER, British Columbia, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Whistler Medical Marijuana Corp. (“WMMC” or the “Company”), Canada’s original organic certified producer of medical cannabis, is pleased to announce they [...]
IntelGenx Announces Pricing of $12 Million Equity Offering
18/10/2018
SAINT LAURENT, Quebec, Oct. 18, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “ Company ” or “ IntelGenx ”) announced today the pricing of an agency offering (the “ Offering ”) of [...]
iAnthus and MPX Bioceutical Announce Transformational Combination, Expands U.S. Footprint to 10 States
18/10/2018
NEW YORK and TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQX: ITHUF), and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:MPXEF) announced [...]
BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer
18/10/2018
MELVILLE, N.Y., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced the [...]
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
18/10/2018
RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today [...]
Making Breast Cancer Surgery Easier for Women: Over 50,000 Women in U.S. Experienced Wire-free Breast Tumor Localization with SAVI SCOUT®
18/10/2018
ALISO VIEJO, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the world leader in wire-free breast localization, announced that over 375 hospitals across the United States have collectively performed over [...]
RefleXion to Unveil New Approach to Cancer Treatment at ASTRO
18/10/2018
Biology-guided Radiotherapy May Improve Physician Confidence in Treatment of Multiple Tumors HAYWARD, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- RefleXion Medical , a biotargeting oncology company using each cancer’s [...]
CTV Toronto Highlights FSD Pharma’s Cobourg Facility -- CFN Media
18/10/2018
SEATTLE, Oct. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Predictive Technology Group Appoints Charles Andres to Its Scientific Advisory Board
18/10/2018
SALT LAKE CITY, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]
Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Brazil for the Treatment of Mucopolysaccharidosis VII
18/10/2018
Mepsevii, an enzyme replacement therapy, is the first treatment approved in Latin America for this rare genetic disease NOVATO, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a [...]
Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy
18/10/2018
Intellia scientists present first robust demonstration of CRISPR-mediated insertion of transgenes in the liver Non-human primate data show high correlation achieved between liver edit and reduction of TTR protein High [...]
OpGen Announces Pricing of Public Offering of Common Stock
18/10/2018
GAITHERSBURG, Md., Oct. 18, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced the pricing of an underwritten public offering of approximately 2.2 million shares of its common stock at a public offering [...]
Organovo Announces Release Date for Fiscal Second-Quarter 2019 Financial Results
18/10/2018
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, November 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer
18/10/2018
NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Progressive Care Inc. Announces Beta Launch of New Proprietary Tele-PharmCo Software Platform for Real-Time Patient-to-Pharmacist Video Interactions
18/10/2018
MIAMI, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced the beta launch of its new proprietary tele-pharmacy software [...]
Evolus to Release Third Quarter 2018 Financial Results on Monday, November 5, 2018
18/10/2018
IRVINE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that it will release 2018 third quarter financial results after the close of U.S [...]
swyMed Joins AT&T's FirstNet Dealer Program
18/10/2018
Industry Experts in Public Safety Can Now Market, Promote and Co-Sell FirstNet Services LEXINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- swyMed, a provider of industry leading telemedicine and connectivity solutions [...]
Samumed to Present Preclinical Data on SM07883 at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) Congress
18/10/2018
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it will present preclinical data on the company’s novel DYRK1A inhibitor, SM07883, a potential first-in-class drug for the treatment of [...]

Pages